Orthofix (OFIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Orthofix Medical Inc. (OFIX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Orthofix Medical Inc. (OFIX) Q1 2026 Earnings Call Transcript
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 189 | $2,756.42 | $2,132.86 | -$623.56 | -22.62% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 69 | $791.43 | $779.2 | -$12.23 | -1.55% |
| BG Bart Gancher Intech Investment Management LLC | 12,880 | $216,351.8 | $145,608.4 | -$70,743.4 | -32.7% |
Anthony Scaramucci SkyBridge Capital II LLC | 2.7M | $40.45M | $30.47M | -$9.98M | -24.68% |
Point72 Asset Management LP Point72 Asset Management LP | 158,880 | $2.15M | $1.79M | -$356,674.03 | -16.61% |
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CB Caitlin Burrows Canaccord Genuity | 5,122.95 | $54,126.09 | $58,119.88 | $3,993.79 | 7.38% |
| Health Care Equipment & Supplies Industry | Healthcare Sector | Massimo Calafiore CEO | NASDAQ (NGS) Exchange | 68752M108 CUSIP |
| US Country | 1,605 Employees | - Last Dividend | - Last Split | 24 Apr 1992 IPO Date |
Orthofix Medical Inc., a prominent company in the spine and orthopedics sector, operates extensively throughout the United States, as well as in Italy, Germany, the United Kingdom, France, Brazil, and other global regions. The company has structured its operations into two primary divisions: Global Spine and Global Orthopedics, catering to a wide range of spinal and orthopedic healthcare needs. Initially established in 1980, the organization underwent a rebranding from Orthofix International N.V. to Orthofix Medical Inc. in 2018 and is strategically headquartered in Lewisville, Texas. Through a combination of direct sales representatives and distributor channels, Orthofix Medical Inc. services an expansive client base, including hospitals, healthcare facilities, and medical professionals worldwide.
Orthofix Medical Inc.'s product line and services are distinguished between its two operational segments, Global Spine and Global Orthopedics, each tailored to address specific medical conditions and treatment requirements.
Under the Global Spine segment, these devices are engineered to enhance bone fusion, offering both adjunctive and noninvasive treatments for cervical and lumbar spine issues. They also provide therapeutic treatments for non-spine related conditions, making them versatile tools in bone health and recovery.
These products, also a part of the Global Spine segment, are designed, developed, and marketed for use in surgical spine procedures. They support the spine's natural motion while ensuring stable fixation, catering to a broad range of surgical needs and patient outcomes.
The Global Spine segment offers a suite of biological solutions, including fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers and tissues. These products aid physicians in treating various spinal and orthopedic conditions by facilitating natural bone growth and healing.
This innovative technology suite features tracked surgical tools, intelligent software, and imaging equipment. Leveraging machine-vision and optical innovations, these technologies enhance the precision and safety of spinal surgeries, falling under the Global Spine segment's umbrella.
The Global Orthopedics segment offers a comprehensive range of external and internal fixation products. Paired with enabling digital technologies, these solutions support the entire patient treatment pathway, addressing various orthopedic conditions unrelated to the spine.